Physician profile
Anna Sandstrom
NPI 1043382856
$4,832.62
in general payments reported to CMS, 2019-2025
32 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.27 · 2020: $271 · 2021: $342 · 2022: $1,263 · 2023: $776 · 2024: $1,118 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,891 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,890.78 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $480.41 | 2022-2025 | Skytrofa |
| Tandem Diabetes Care, INC. | $377.50 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $371.00 | 2019-2025 | Omnipod |
| Azurity Pharmaceuticals, INC. | $300.51 | 2023-2025 | Triptodur, Triptodur |
| Neurocrine Biosciences, INC. | $272.72 | 2024-2025 | |
| Dexcom, INC. | $270.69 | 2021-2024 | Dexcom G6 Transmitter |
| Tolmar, INC. | $269.53 | 2023-2025 | Fensolvi |
| Medtronic, INC. | $264.24 | 2022-2025 | Minimed 780g |
| Arbor Pharmaceuticals, INC. | $252.47 | 2020-2022 | |
| Xeris Pharmaceuticals, INC. | $221.26 | 2020-2025 | Gvoke Hypopen |
| Novo Nordisk INC | $208.54 | 2024 | Sogroya |
| Sequel Med Tech, LLC | $202.29 | 2025 | Twiist |
| Abbott Laboratories | $177.38 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Sanofi-Aventis U.S. LLC | $175.92 | 2024-2025 | |
| Amphastar Pharmaceuticals, INC. | $151.40 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $133.89 | 2020-2025 | Strensiq |
| Pfizer INC. | $129.51 | 2022-2025 | |
| Tolmar Pharmaceuticals, INC. | $82.35 | 2021-2022 | |
| Rhythm Pharmaceuticals, INC. | $72.99 | 2023-2024 | Imcivree, Imcivree |
| Eton Pharmaceuticals, INC. | $62.78 | 2020-2021 | |
| Zealand Pharma US, INC. | $47.71 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $38.55 | 2021-2022 | |
| Abbvie INC. | $37.01 | 2019-2023 | Lupron Depot |
| Endo Pharmaceuticals INC. | $36.53 | 2021-2024 | Supprelin |
| Soleno Therapeutics, INC. | $34.30 | 2025 | Vykat Xr |
| Intuity Medical INC | $32.97 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Companion Medical, INC. | $29.04 | 2020 | |
| Beta Bionics, INC. | $23.70 | 2024 | Ilet Bionic Pancreas |
| Kyowa Kirin, INC. | $22.67 | 2025 | |
| Chiesi USA, INC. | $18.93 | 2024 | Myalept |
| Medtronic Minimed, INC. | $17.02 | 2020 | |
| Vistapharm, INC. | $16.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Sandstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.